Potassium homoeostasis and pathophysiology of hyperkalaemia

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Potassium homoeostasis and pathophysiology of hyperkalaemia. / Kjeldsen, Keld Per; Schmidt, Thomas Andersen.

I: European Heart Journal Supplements, Bind 21, Nr. Suppl. A, 2019, s. A2-A5.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Kjeldsen, KP & Schmidt, TA 2019, 'Potassium homoeostasis and pathophysiology of hyperkalaemia', European Heart Journal Supplements, bind 21, nr. Suppl. A, s. A2-A5. https://doi.org/10.1093/eurheartj/suy033

APA

Kjeldsen, K. P., & Schmidt, T. A. (2019). Potassium homoeostasis and pathophysiology of hyperkalaemia. European Heart Journal Supplements, 21(Suppl. A), A2-A5. https://doi.org/10.1093/eurheartj/suy033

Vancouver

Kjeldsen KP, Schmidt TA. Potassium homoeostasis and pathophysiology of hyperkalaemia. European Heart Journal Supplements. 2019;21(Suppl. A):A2-A5. https://doi.org/10.1093/eurheartj/suy033

Author

Kjeldsen, Keld Per ; Schmidt, Thomas Andersen. / Potassium homoeostasis and pathophysiology of hyperkalaemia. I: European Heart Journal Supplements. 2019 ; Bind 21, Nr. Suppl. A. s. A2-A5.

Bibtex

@article{a276cda13f854f67bd8069acc1ca080c,
title = "Potassium homoeostasis and pathophysiology of hyperkalaemia",
abstract = "Determination of potassium level is one of the most frequent laboratory tests in clinical medicine. Hyperkalaemia is defined as a potassium level >5.0 mmol/L and is one of the most clinically important electrolyte abnormalities, because it may cause dangerous cardiac arrhythmia and sudden cardiac death. Here, we review methodological challenges in the determination of potassium levels, important clinical aspects of the potassium homoeostasis as well as of the pathophysiology of hyperkalaemia.",
keywords = "Potassium, Plasma potassium, Serum potassium, Potassium homoeostasis, Hyperkalaemia, Na, K-Pumps, K-ATPase, Sodium, Potassium-Adenosinetriphosphatase, Arrhythmia, Sudden cardiac death",
author = "Kjeldsen, {Keld Per} and Schmidt, {Thomas Andersen}",
year = "2019",
doi = "10.1093/eurheartj/suy033",
language = "English",
volume = "21",
pages = "A2--A5",
journal = "European Heart Journal Supplements",
issn = "1554-2815",
publisher = "Oxford University Press",
number = "Suppl. A",

}

RIS

TY - JOUR

T1 - Potassium homoeostasis and pathophysiology of hyperkalaemia

AU - Kjeldsen, Keld Per

AU - Schmidt, Thomas Andersen

PY - 2019

Y1 - 2019

N2 - Determination of potassium level is one of the most frequent laboratory tests in clinical medicine. Hyperkalaemia is defined as a potassium level >5.0 mmol/L and is one of the most clinically important electrolyte abnormalities, because it may cause dangerous cardiac arrhythmia and sudden cardiac death. Here, we review methodological challenges in the determination of potassium levels, important clinical aspects of the potassium homoeostasis as well as of the pathophysiology of hyperkalaemia.

AB - Determination of potassium level is one of the most frequent laboratory tests in clinical medicine. Hyperkalaemia is defined as a potassium level >5.0 mmol/L and is one of the most clinically important electrolyte abnormalities, because it may cause dangerous cardiac arrhythmia and sudden cardiac death. Here, we review methodological challenges in the determination of potassium levels, important clinical aspects of the potassium homoeostasis as well as of the pathophysiology of hyperkalaemia.

KW - Potassium

KW - Plasma potassium

KW - Serum potassium

KW - Potassium homoeostasis

KW - Hyperkalaemia

KW - Na

KW - K-Pumps

KW - K-ATPase

KW - Sodium

KW - Potassium-Adenosinetriphosphatase

KW - Arrhythmia

KW - Sudden cardiac death

U2 - 10.1093/eurheartj/suy033

DO - 10.1093/eurheartj/suy033

M3 - Journal article

C2 - 30837798

VL - 21

SP - A2-A5

JO - European Heart Journal Supplements

JF - European Heart Journal Supplements

SN - 1554-2815

IS - Suppl. A

ER -

ID: 223822846